In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies by Elena Iemma | Apr 1, 2024
Development of IFNβ-1a versions with reduced immunogenicity and full in vitro biological activity for the treatment of multiple sclerosis by Elena Iemma | Nov 15, 2023
